English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1945]
News [3584]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Sugar chain on cell surface directs cancer cells to die
Sugar chain on cell surface directs cancer cells to die
Smart nanoparticle shows that intermittent fasting may protect the heart from damage during chemotherapy
Smart nanoparticle shows that intermittent fasting may protect the heart from damage during chemotherapy
Inhibiting the function of the PD-1 protein has shown high therapeutic efficacy in cancer immunotherapy
Inhibiting the function of the PD-1 protein has shown high therapeutic efficacy in cancer immunotherapy
Breast cancer: new drug shrinks brain metastases
Breast cancer: new drug shrinks brain metastases
Portable cancer testing expands in sub-Saharan Africa
Portable cancer testing expands in sub-Saharan Africa
Can exercise boost chemotherapy’s effectiveness, improve outlook for colon cancer survivors?
Can exercise boost chemotherapy’s effectiveness, improve outlook for colon cancer survivors?
Researchers identify critical regulators controlling T-cell homeostasis which could improve cancer therapies, vaccines of the future
Researchers identify critical regulators controlling T-cell homeostasis which could improve cancer therapies...
Skin cancer cells harness nerve cell gene to drill through and invade new tissues
Skin cancer cells harness nerve cell gene to drill through and invade new tissues
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III NSCLC
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for...
WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs best supportive care in resected NSCLC
WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs best supportive...
<1...7879808182...359>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top